Take your research to the next level

Steve Yang, Ph.D.


A pharmaceutical industry leader recognized for building R&D and service capabilities, delivering research and early development portfolios of drug candidates, and establishing R&D partnerships in US, Europe, China and other Asian and emerging markets. Before joining WuXi AppTec, Dr. Yang was Vice President and Head of Asia and Emerging Markets IMED at AstraZeneca, and served as Vice President and Head of Asia R&D at Pfizer and as Executive Director and head of Pfizer's global R&D strategic management group. Dr. Yang received his Ph.D. in pharmaceutical chemistry from the University of California, San Francisco.

Letian Kuai, Ph.D.

Vice President, Head of WuXi Biology, Head of Discovery Biology Unit (DBU), Head of WuXi Biology HitS

Letian Kuai received his Ph.D. in biochemistry from the University of Rochester in 2004, followed by post-doctoral training at the Broad Institute of MIT and Harvard. At a leading pharmaceutical company, he became a key innovator and contributor to the development of DNA-Encoded Library (DEL) technology. Dr. Kuai joined WuXi AppTec HitS in 2018, and built an integrated suite of high-quality and customizable solutions, with capabilities spanning protein and antibody sciences, DNA-encoded libraries, biophysics, and structural biology.

Peiyuan Lin, Ph.D.

Senior Vice President, HD Biosciences

Peiyuan Lin joined HD Biosciences (a WuXi AppTec subsidiary company) as Senior Vice President in 2008, leading R&D efforts in drug discovery. Dr. Lin earned her Ph.D. in molecular pharmacology from the University of Cincinnati College of Medicine in 1988. Since then, she has gained extensive knowledge and experience working internationally over the last 30 years in both pharmaceutical drug discovery and the CRO industry.

Qingyang Gu, Ph.D.

Head of Oncology & Immunology Unit (OIU)

Dr. Qingyang Gu joined WuXi AppTec in 2012. He has been dedicated to working in the fields of tumor biology, anti-tumor therapeutics development, and translational medicine for more than two decades, in which he has gained a wealth of experience and expertise in biomedical sciences and team management.

Declan Ryan, Ph.D.

Vice President, US Business Development

Over 20 years' experience in R&D in both research and business development roles at 3-Dimensional Pharmaceuticals, Novartis, Johnson & Johnson, AMRI and Shanghai ChemPartner. Declan Ryan earned his Ph.D. from the University of Lausanne, Switzerland, and he completed postdoctoral studies at Yale University and the University of Pittsburgh, USA.

Dave Madge, Ph.D.

Vice President, EU and Israel BD Head

Over 20 years’ experience working within academia, biotech and CRO companies. Dave Madge is the former VP Research at Xention, founder of NCE Discovery (now Domainex) and a member of the integrated biomedical research group at University College London. Dave started his career at the Wellcome Foundation and received his Ph.D. in chemistry from Imperial College, London.

× peptide, amino acid

Contact An Expert Today!